Go Pro
→ Your book attached (From Profits Run) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Accuray Incorporated stock logo
ARAY
Accuray
$0.29
+0.8%		$0.29
$0.22
▼
$2.10
$33.90M1.391.55 million shs993,780 shs
Hyperfine, Inc. stock logo
HYPR
Hyperfine
$0.96
-2.7%		$1.23
$0.85
▼
$2.22
$94.80M1.42732,139 shs904,666 shs
Kewaunee Scientific Corporation stock logo
KEQU
Kewaunee Scientific
$37.39
-1.3%		$36.83
$33.27
▼
$60.89
$106.36M0.725,380 shs1,817 shs
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
$1.89
+5.0%		$1.83
$1.60
▼
$4.67
$126.94M1.06504,403 shs630,530 shs
Don't Wait for the OpenAI IPO Cover
Don't Wait for the OpenAI IPO

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Accuray Incorporated stock logo
ARAY
Accuray
0.00%+6.30%+7.95%-25.00%-78.24%
Hyperfine, Inc. stock logo
HYPR
Hyperfine
0.00%+2.05%-15.11%-43.49%-18.38%
Kewaunee Scientific Corporation stock logo
KEQU
Kewaunee Scientific
0.00%+4.66%+4.72%+0.55%-29.93%
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
0.00%+9.88%+1.61%-11.27%-34.15%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Accuray Incorporated stock logo
ARAY
Accuray
$0.29
+0.8%		$0.29
$0.22
▼
$2.10
$33.90M1.391.55 million shs993,780 shs
Hyperfine, Inc. stock logo
HYPR
Hyperfine
$0.96
-2.7%		$1.23
$0.85
▼
$2.22
$94.80M1.42732,139 shs904,666 shs
Kewaunee Scientific Corporation stock logo
KEQU
Kewaunee Scientific
$37.39
-1.3%		$36.83
$33.27
▼
$60.89
$106.36M0.725,380 shs1,817 shs
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
$1.89
+5.0%		$1.83
$1.60
▼
$4.67
$126.94M1.06504,403 shs630,530 shs
Don't Wait for the OpenAI IPO Cover
Don't Wait for the OpenAI IPO

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Accuray Incorporated stock logo
ARAY
Accuray
0.00%+6.30%+7.95%-25.00%-78.24%
Hyperfine, Inc. stock logo
HYPR
Hyperfine
0.00%+2.05%-15.11%-43.49%-18.38%
Kewaunee Scientific Corporation stock logo
KEQU
Kewaunee Scientific
0.00%+4.66%+4.72%+0.55%-29.93%
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
0.00%+9.88%+1.61%-11.27%-34.15%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Accuray Incorporated stock logo
ARAY
Accuray
1.67
Reduce$2.00601.75% Upside
Hyperfine, Inc. stock logo
HYPR
Hyperfine
2.33
Hold$1.7886.74% Upside
Kewaunee Scientific Corporation stock logo
KEQU
Kewaunee Scientific
2.00
HoldN/AN/A
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
3.00
Buy$6.63250.53% Upside

Current Analyst Ratings Breakdown

Latest ARAY, MBOT, KEQU, and HYPR Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/4/2026
Accuray Incorporated stock logo
ARAY
Accuray
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D-)
7/22/2026
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
Zacks Research logo
Zacks Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeHold ➝ Strong-Buy
7/17/2026
Hyperfine, Inc. stock logo
HYPR
Hyperfine
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D-)
7/14/2026
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
HC Wainwright logo
HC Wainwright
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy
7/8/2026
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D-)
7/8/2026
Accuray Incorporated stock logo
ARAY
Accuray
BTIG Research logo
BTIG Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingNeutral
6/30/2026
Kewaunee Scientific Corporation stock logo
KEQU
Kewaunee Scientific
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingHold (C)
6/3/2026
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
Loop Capital logo
Loop Capital
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Set Price Target$4.00
5/13/2026
Hyperfine, Inc. stock logo
HYPR
Hyperfine
B. Riley Financial, Inc. logo
B. Riley Financial
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy
5/12/2026
Accuray Incorporated stock logo
ARAY
Accuray
Jefferies Financial Group Inc. logo
Jefferies Financial Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeBuy ➝ Hold
(Data available from 8/9/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Accuray Incorporated stock logo
ARAY
Accuray
$458.51M0.07$0.04 per share6.39$0.72 per share0.40
Hyperfine, Inc. stock logo
HYPR
Hyperfine
$11.40M8.32N/AN/A$0.42 per share2.27
Kewaunee Scientific Corporation stock logo
KEQU
Kewaunee Scientific
$282M0.38$6.00 per share6.23$26.80 per share1.39
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
N/AN/AN/AN/A$1.15 per shareN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Accuray Incorporated stock logo
ARAY
Accuray
-$1.59M-$0.37N/AN/AN/A-10.76%-79.43%-10.38%8/12/2026 (Estimated)
Hyperfine, Inc. stock logo
HYPR
Hyperfine
-$35.57M-$0.41N/AN/AN/A-210.75%-99.81%-64.95%N/A
Kewaunee Scientific Corporation stock logo
KEQU
Kewaunee Scientific
$9.62M$3.2211.61N/AN/A3.41%14.10%5.55%9/16/2026 (Estimated)
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
-$13.14M-$0.26N/AN/AN/AN/A-21.84%-20.71%8/11/2026 (Estimated)

Latest ARAY, MBOT, KEQU, and HYPR Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/12/2026Q4 2026
Accuray Incorporated stock logo
ARAY
Accuray
-$0.03N/AN/AN/A$105.30 millionN/A
8/11/2026Q2 2026
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
-$0.08N/AN/AN/A$0.33 millionN/A
8/6/2026Q2 2026
Hyperfine, Inc. stock logo
HYPR
Hyperfine
-$0.09-$0.09N/A-$0.09$4.14 million$3.90 million
6/23/2026Q4 2026
Kewaunee Scientific Corporation stock logo
KEQU
Kewaunee Scientific
N/A$1.14N/A$1.13N/A$71.40 million
5/13/2026Q1 2026
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
-$0.08-$0.05+$0.03-$0.05$0.30 million$0.11 million
5/12/2026Q1 2026
Hyperfine, Inc. stock logo
HYPR
Hyperfine
-$0.09-$0.09N/A-$0.09$3.54 million$3.90 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Accuray Incorporated stock logo
ARAY
Accuray
N/AN/AN/AN/AN/A
Hyperfine, Inc. stock logo
HYPR
Hyperfine
N/AN/AN/AN/AN/A
Kewaunee Scientific Corporation stock logo
KEQU
Kewaunee Scientific
N/AN/AN/AN/AN/A
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Accuray Incorporated stock logo
ARAY
Accuray
3.21
1.42
0.66
Hyperfine, Inc. stock logo
HYPR
Hyperfine
0.38
5.52
4.90
Kewaunee Scientific Corporation stock logo
KEQU
Kewaunee Scientific
0.53
2.18
1.55
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
0.01
22.59
21.93

Institutional Ownership

CompanyInstitutional Ownership
Accuray Incorporated stock logo
ARAY
Accuray
64.08%
Hyperfine, Inc. stock logo
HYPR
Hyperfine
15.03%
Kewaunee Scientific Corporation stock logo
KEQU
Kewaunee Scientific
32.69%
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
16.30%

Insider Ownership

CompanyInsider Ownership
Accuray Incorporated stock logo
ARAY
Accuray
4.36%
Hyperfine, Inc. stock logo
HYPR
Hyperfine
26.33%
Kewaunee Scientific Corporation stock logo
KEQU
Kewaunee Scientific
14.10%
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
4.74%
CompanyEmployeesShares OutstandingFree FloatOptionable
Accuray Incorporated stock logo
ARAY
Accuray
1,040118.96 million113.78 millionOptionable
Hyperfine, Inc. stock logo
HYPR
Hyperfine
19099.27 million73.13 millionOptionable
Kewaunee Scientific Corporation stock logo
KEQU
Kewaunee Scientific
1,2312.87 million2.46 millionNot Optionable
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
2067.17 million63.98 millionOptionable

Recent News About These Companies

Microbot Medical (MBOT) Projected to Release Quarterly Earnings on Tuesday
 |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30950836
Microbot Medical (MBOT) Expected to Announce Quarterly Earnings on Tuesday
August 4, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/microbot-medical-mbot-expected-to-announce-quarterly-earnings-on-tuesday-2026-08-04/
Microbot Medical Inc. (NASDAQ:MBOT) Given Consensus Rating of "Buy" by Brokerages
August 4, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/microbot-medical-inc-nasdaqmbot-given-consensus-rating-of-buy-by-brokerages-2026-08-04/
Contrasting Microbot Medical (NASDAQ:MBOT) & 908 Devices (NASDAQ:MASS)
July 29, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30927803
Microbot Medical (NASDAQ:MBOT) Rating Increased to Strong-Buy at Zacks Research
July 24, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/microbot-medical-nasdaqmbot-rating-increased-to-strong-buy-at-zacks-research-2026-07-24/
New Strong Buy Stocks for July 23rd
July 23, 2026  |  zacks.comhttps://www.zacks.com/commentary/2957760/new-strong-buy-stocks-for-july-23rd?cid=cs-stocknewsapi-ft-zacks_1_rank_additions-2957760
Microbot Medical to Present on Endovascular Robotics at Society of Robotic Surgery Annual Meeting
July 21, 2026  |  quiverquant.comQ
Microbot Medical® Among Featured Companies Showcasing Novel Robotic Technologies and Digital Surgery Applications at the Society of Robotic Surgery Annual Meeting
July 21, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/07/21/3330454/0/en/microbot-medical-among-featured-companies-showcasing-novel-robotic-technologies-and-digital-surgery-applications-at-the-society-of-robotic-surgery-annual-meeting.html
HC Wainwright Issues Optimistic Estimate for MBOT Earnings
July 15, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/hc-wainwright-issues-optimistic-estimate-for-mbot-earnings-2026-07-15/
Microbot Medical Inc. (NASDAQ:MBOT) Given Consensus Recommendation of "Moderate Buy" by Brokerages
July 10, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/microbot-medical-inc-nasdaqmbot-given-consensus-recommendation-of-moderate-buy-by-brokerages-2026-07-10/
Microbot Medical® Reports Over 100% Revenue and Customer Growth as Procedure Volume Also Rises in the Second Quarter of 2026
July 7, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/07/07/3323187/0/en/microbot-medical-reports-over-100-revenue-and-customer-growth-as-procedure-volume-also-rises-in-the-second-quarter-of-2026.html
Microbot Medical® Increases Manufacturing Capacity as Demand for the LIBERTY® System Rises; Enters into Strategic Agreement with Sanmina, a Global Manufacturing Leader
June 30, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/06/30/3319669/0/en/microbot-medical-increases-manufacturing-capacity-as-demand-for-the-liberty-system-rises-enters-into-strategic-agreement-with-sanmina-a-global-manufacturing-leader.html
Microbot Medical® Wins Surgical Robotics Industry Award for the LIBERTY® Endovascular Robotic System
June 25, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/06/25/3317546/0/en/microbot-medical-wins-surgical-robotics-industry-award-for-the-liberty-endovascular-robotic-system.html
Microbot Medical® Announces First Health System in Pennsylvania to Adopt the LIBERTY® Endovascular Robotic System
June 23, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/06/23/3315975/0/en/microbot-medical-announces-first-health-system-in-pennsylvania-to-adopt-the-liberty-endovascular-robotic-system.html
Microbot Medical Expands Federal Access for LIBERTY Robotics
June 17, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/markets-news/Tipranks/2516271/microbot-medical-expands-federal-access-for-liberty-robotics/
Microbot Medical® Enters Into an Agreement to Expand Access for America’s Veteran and Military Patient Populations
June 16, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/microbot-medical-enters-agreement-expand-123000148.html
Microbot Medical® Enters Into an Agreement to Expand Access for America's Veteran and Military Patient Populations
June 16, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/06/16/3312592/0/en/microbot-medical-enters-into-an-agreement-to-expand-access-for-america-s-veteran-and-military-patient-populations.html
Microbot Medical® Announces a Notable Health System as the First in Michigan to Adopt the LIBERTY® Endovascular Robotic System
June 9, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/06/09/3308831/0/en/microbot-medical-announces-a-notable-health-system-as-the-first-in-michigan-to-adopt-the-liberty-endovascular-robotic-system.html
Microbot Medical® Secures the First Healthcare System in North Carolina to Adopt the LIBERTY® Endovascular Robotic System
June 2, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/06/02/3305175/0/en/microbot-medical-secures-the-first-healthcare-system-in-north-carolina-to-adopt-the-liberty-endovascular-robotic-system.html
Microbot Medical Draws Attention Amid Healthcare Stock Growth
May 31, 2026  |  kalkinemedia.comK
Microbot Medical® Receives Its First International Regulatory Approval for the Commercialization of the LIBERTY® Endovascular Robotic System
May 26, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/05/26/3301096/0/en/microbot-medical-receives-its-first-international-regulatory-approval-for-the-commercialization-of-the-liberty-endovascular-robotic-system.html

New MarketBeat Followers Over Time

Media Sentiment Over Time

Accuray stock logo

Accuray NASDAQ:ARAY

$0.28 +0.00 (+0.81%)
Closing price 08/7/2026 04:00 PM Eastern
Extended Trading
$0.29 +0.00 (+1.05%)
As of 08/7/2026 07:42 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Accuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Asia, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, and China. It offers the CyberKnife platform, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside the brain, including tumors on or near the spine and in the breast, kidney, liver, lung, pancreas, and prostate. The company also provides the TomoTherapy platform, including the Radixact System, which allows for integrated radiation treatment planning, delivery, and data management, enabling clinicians to deliver ultra-precise treatments to approximately 50 patients per day; iDMS data management system, a fully integrated treatment planning and data management systems; and Accuray precision treatment planning system, a treatment planning and data management systems. In addition, it offers post-contract customer support, installation, training, and other professional services. The company primarily markets its products directly to customers, including hospitals and stand-alone treatment facilities through its sales organization, as well as to customers through sales agents and group purchasing organizations in the United States; and to customers directly and through distributors and sales agents internationally. Accuray Incorporated was incorporated in 1990 and is headquartered in Madison, Wisconsin.

Hyperfine stock logo

Hyperfine NASDAQ:HYPR

$0.96 -0.03 (-2.75%)
Closing price 08/7/2026 04:00 PM Eastern
Extended Trading
$0.95 -0.01 (-0.52%)
As of 08/7/2026 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Hyperfine, Inc., a medical device company, provides magnetic resonance imaging (MRI) products in the United States. The company offers Swoop Portable MR imaging system, which offers portable brain neuroimaging; and support and technical assistance services. It serves ICU, comprehensive, and primary stroke accredited facilities through direct sales and distributors. Hyperfine, Inc. was founded in 2014 and is based in Guilford, Connecticut.

Kewaunee Scientific stock logo

Kewaunee Scientific NASDAQ:KEQU

$37.38 -0.50 (-1.31%)
Closing price 08/7/2026 03:59 PM Eastern
Extended Trading
$36.70 -0.69 (-1.85%)
As of 08/7/2026 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks. The company's laboratory products are used in chemistry, physics, biology, and other general science laboratories in the pharmaceutical, biotechnology, industrial, chemical, commercial, educational, government, and health care markets; and technical products are used in facilities manufacturing computers and light electronics and by users of computer and networking furniture. It sells its products primarily through dealers, its subidiaries, and a national distributor. The company was founded in 1906 and is headquartered in Statesville, North Carolina.

Microbot Medical stock logo

Microbot Medical NASDAQ:MBOT

$1.89 +0.09 (+5.00%)
Closing price 08/7/2026 04:00 PM Eastern
Extended Trading
$1.90 +0.01 (+0.53%)
As of 08/7/2026 07:37 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development. Microbot Medical Inc. was founded in 2010 and is based in Braintree, Massachusetts.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas